Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac/HPMC for Dry Eye Symptoms
NCT03693183Phase 2Withdrawn
- Start
- Mar 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac tromethamine in dry eye syndrome (DED). Planned start Mar 2009; status: withdrawn.
02
Drugs
ketorolac tromethamine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03693183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03693183.